Avanos Names CFO Greiner Interim CEO as Woody Retires, 3Q Sales Slip

Dow Jones
2024/10/30

By Rob Curran

 

Medical-device maker Avanos Medical named Chief Financial Officer Michael Greiner interim chief executive, taking the reins from veteran Joe Woody, as the company also posted a down-tick in third-quarter sales.

Greiner, who also holds the title of chief transformation officer, joined Avanos as chief financial officer on Jan. 1, 2020.

Woody is retiring after seven years at the helm of Avanos, and he will assist in the transition, in a consulting capacity, through April, 2025, the company said.

For the third quarter, the Alpharetta, Ga., maker of non-narcotic pain-medication pumps and other equipment swung to a profit of $4.3 million, or 9 cents a share, from a loss of $3.7 million, or 8 cents a share, a year earlier.

Sales ticked down 0.5% to $170.4 million.

"We had a few strong pockets of sales performance for the quarter, including continued execution in our digestive health business and double digit growth for Game Ready and IVP," said Greiner, in a statement. "However, underperformance in our surgical pain category, particularly ON-Q, negatively impacted our overall sales performance."

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

October 30, 2024 08:20 ET (12:20 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10